SYK

Stryker
D

SYK

Arincen80/100B

Stryker company profile

CEO
Kevin A. Lobo
Employees
56,000
Headquarters
1941 Stryker Way, Portage, MI 49002, US
Sector
Healthcare
Industry
Medical - Devices
IPO date
17 Mar 1980
Stock exchange
NYSE
ISIN
US8636671013

Website:stryker.com

About the company

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Employees

Stryker had about 56,000 employees at the end of fiscal year 2025 (31 December 2025), by its annual report. That is 5.7% more than a year before.

Employees Change on the year
Fiscal yearEmployeesChange on the yearRevenue per employeeNet income per employee
FY202556,000+5.66%448.50K USD57.96K USD
FY202453,000+1.92%426.32K USD56.47K USD
FY202352,000+1.96%394.19K USD60.87K USD
FY202251,000+10.87%361.75K USD46.24K USD
FY202146,000+6.98%371.91K USD43.35K USD
FY202043,000+7.50%333.74K USD37.19K USD
FY201940,000+11.11%372.10K USD52.08K USD
FY201836,000+9.09%377.81K USD98.69K USD
FY201733,0000.00%377.09K USD30.91K USD
FY201633,000+22.22%343.18K USD49.91K USD
FY201527,000+3.85%368.37K USD53.30K USD
FY201426,000+4.00%372.12K USD19.81K USD
FY201325,000+13.58%360.84K USD40.24K USD
FY201222,010+3.62%393.32K USD58.97K USD
FY201121,241+6.01%391.08K USD63.32K USD
FY201020,036+7.82%365.34K USD63.56K USD
FY200918,582+5.62%361.81K USD59.60K USD
FY200817,594+9.78%381.85K USD65.24K USD
FY200716,026-14.78%374.42K USD63.48K USD
FY200618,806+8.93%287.44K USD41.35K USD
FY200517,265+8.65%282.16K USD39.11K USD
FY200415,891+7.65%268.22K USD29.31K USD
FY200314,762+5.11%245.58K USD30.72K USD
FY200214,045+9.39%214.43K USD24.61K USD
FY200112,839+6.25%202.69K USD20.80K USD
FY200012,084+10.61%189.46K USD18.29K USD
FY199910,925-0.45%192.56K USD1.78K USD
FY199810,974+92.83%100.53K USD3.61K USD
FY19975,691+7.91%172.22K USD22.02K USD
FY19965,274+13.93%172.56K USD19.81K USD
FY19954,629+9.67%188.38K USD18.79K USD
FY19944,221+30.76%161.55K USD17.15K USD
FY19933,228—172.65K USD18.65K USD

Employees at each fiscal year end, as the company reports them in its annual report (10-K); revenue and net income per employee are the fiscal year's over that count.

Who owns Stryker

Institutions such as funds, banks and insurers held 80.9% of Stryker's shares on 30 June 2026, 2,341 of them reporting holdings to the SEC; the rest is held by individual investors and other shareholders.

Institutions 80.9%Other shareholders 19.1%

Shares free to trade

Free float 345.81M shares ·90.8% Closely held 34.88M shares ·9.2%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

How Stryker pays its executives

The chief executive was paid 21.40M USD for fiscal 2025, 78% of it in shares and options.

Name and positionSalaryStock awardsOption awardsCash incentiveOther payTotal pay
Kevin A. Lobo Chair, Chief Executive Officer and President1.49M USD9.76M USD6.92M USD2.25M USD974.91K USD21.40M USD
Spencer S. Stiles Group President, Orthopaedics792.50K USD2.69M USD1.90M USD760.00K USD188.08K USD6.33M USD
J. Andrew Pierce Group President, MedSurg and Neurotechnology792.50K USD2.69M USD1.90M USD754.15K USD188.08K USD6.32M USD
Preston W. Wells Vice President, Chief Financial Officer653.43K USD1.84M USD1.30M USD514.56K USD103.34K USD4.41M USD
Viju S. Menon Group President, Global Quality and Operations675.00K USD1.65M USD1.17M USD578.00K USD167.48K USD4.24M USD
Glenn S. Boehnlein Advisor to the Chief Executive Officer and Former Vice President, Chief Financial Officer800.00K USD——800.00K USD293.05K USD1.89M USD

FY2025 · From the company's proxy statements to the SEC: what each named executive was paid for the fiscal year, shares and options at their value when granted. The latest filing

Common questions about Stryker

Source: Financial Modeling Prep